Two health workers infected in West Bengal spark rapid containment efforts and regional health checks to curb potential spread of the deadly pathogen.
Deadly Nipah Virus Re-emerges in West Bengal, Asia Heightens Airport Screening:
A deadly virus with a fatality rate up to 75% has reemerged in India’s West Bengal state, infecting two frontline health workers and prompting swift airport screenings in neighboring countries. While the outbreak appears contained with no further cases reported, the incident underscores the persistent threat of zoonotic diseases in densely populated regions. Health authorities are racing to trace the source as Asia remains on high alert.
Nipah Virus Returns to West Bengal After Nearly Two Decades, Sparks Regional Alert:
The alarm sounded in early January when two nurses at a private hospital in Rainy season fell ill with symptoms that quickly escalated from fever and headache to severe neurological complications. By January 11, local labs flagged the cases as suspected Nipah virus infections, and confirmation came two days later from India’s National Institute of Virology in Pune via RT-PCR testing. The patients, who had been in close contact while on duty in late December, were immediately isolated in intensive care.
India’s central and state governments mobilized rapidly. A joint outbreak response team from the Union Health Ministry and West Bengal authorities descended on the area, launching enhanced surveillance, lab testing, and contact tracing. Within days, 196 individuals linked to the cases were identified, monitored, and tested-all came back negative, with no symptoms reported. Public health measures included targeted awareness campaigns in affected districts, emphasizing avoidance of raw date palm sap and fruits potentially contaminated by bats.
The male patient has shown signs of recovery, but the female remains critically ill on ventilator support. Both received remdesivir, a drug repurposed from COVID-19 protocols, highlighting the lack of specific treatments for Nipah. As of late January, the situation is stable, with no new infections detected.
This marks West Bengal’s first Nipah cases in nearly two decades, since a 2007 outbreak in Nadia district that claimed five lives. The reappearance has rippled across Asia, reviving memories of past pandemics and prompting precautionary measures at international gateways.
From Bats to Humans: Nipah’s History and Ongoing Regional Danger:
Nipah virus, first identified in 1998-1999 during an outbreak in Malaysia and Singapore that killed over 100 people and led to the culling of a million pigs, is a paramyxovirus classified as a biosafety level-4 pathogen. Fruit bats of the Pteropus genus, known as flying foxes, serve as natural reservoirs, harboring the virus without illness. Transmission to humans typically occurs through direct contact with infected bats, pigs, or contaminated food like raw date palm sap laced with bat saliva or urine. Human-to-human spread is rare but possible via close contact with bodily fluids, often in healthcare settings.
Symptoms start mild-fever, headache, muscle pain, vomiting-but can swiftly progress to dizziness, altered consciousness, acute encephalitis, and respiratory distress. The case fatality rate ranges from 40% to 75%, depending on detection and care quality, with no approved vaccine or antiviral available. Survivors may face long-term neurological issues.
In India, Nipah has struck sporadically. The 2001 Siliguri outbreak in West Bengal infected 66 and killed 45, linked to human-to-human transmission in hospitals. Kerala has seen repeated clusters since 2018, including a 2023 incident with two fatalities out of six cases. Neighboring Bangladesh reports near-annual outbreaks since 2001, often tied to date palm sap consumption.
The current cases in West Bengal, near the Bangladesh border, highlight regional vulnerabilities where bat habitats overlap with human activity. Climate change and deforestation may increase spillover risks by driving bats closer to communities.
This incident matters because Nipah is on the WHO’s priority pathogens list for its epidemic potential. In a post-COVID world, even small outbreaks can strain health systems and disrupt travel, as seen here.